Available in our Arizona office under the care of Dr. Keith Smigiel.

Quick Take

Therapeutic Plasma Exchange (TPE) is an in-clinic procedure that removes a portion of your blood plasma—where inflammatory molecules, autoantibodies, oxidized lipids, and other harmful circulating factors ride—and replaces it with sterile albumin and balanced fluids. By diluting or removing these damaging compounds, TPE can help reduce cardiovascular risk factors (including stubborn lipoprotein(a)), calm systemic inflammation, and support brain health. Early science also suggests a potential role in healthy aging. (Cleveland Clinic, AHA Journals, PubMed)

What Is Therapeutic Plasma Exchange?

In TPE, whole blood is drawn through an IV line and passed through an apheresis device that separates plasma (the liquid portion) from cellular components. The plasma—where many pathogenic or pro-inflammatory substances circulate—is discarded. Your red and white cells and platelets are then combined with a replacement solution (we use pharmaceutical-grade albumin plus electrolyte fluids) and returned to you in real time. A single session typically exchanges 1–1.5 plasma volumes, reducing targeted circulating factors by ~50–60%, depending on their compartment and rebound kinetics. (Cleveland Clinic, AJKD, Medscape)

Why Consider Plasma Exchange for Prevention & Performance?

1. Cardiovascular Risk Reduction—Especially When Cholesterol Is “Abnormal” or Lp(a) Is Elevated

Patients with genetic or treatment-resistant lipid disorders—particularly elevated lipoprotein(a) [Lp(a)]—face higher rates of atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve disease. TPE modalities developed for lipid removal, broadly termed lipoprotein apheresis, repeatedly show large, acute reductions in LDL particles and Lp(a), with observational data linking long-term treatment to fewer cardiovascular events (myocardial infarction, revascularization) and improved symptom burden (e.g., angina, claudication). (AHA Journals, Lipid Insights, PMC)

The American College of Cardiology recognizes Lp(a) as an independent, causal cardiovascular risk factor; yet drug options remain limited. For high-risk individuals with markedly elevated Lp(a) and progressive disease, extracorporeal removal remains the most effective currently available tool to lower circulating Lp(a) mass. (American College of Cardiology, AHA Journals, PMC)

2. Brain & Cognitive Support

The multicenter AMBAR (Alzheimer’s Management by Albumin Replacement) program tested repeated plasma exchange with albumin in mild-to-moderate Alzheimer’s disease. Results showed a slowing of cognitive and functional decline versus controls, with signal strength greatest in moderate disease and across several cognitive/activities-of-daily-living scales. Proposed mechanisms include removal of amyloid-beta–binding plasma factors, immune modulation, and improved perfusion dynamics. (PubMed, PMC, Alzheimer’s Journals)

3. Systemic Inflammation & Cytokine Reduction

TPE is used clinically to rapidly lower circulating inflammatory mediators in hyper-inflammatory states. In critical illness (including severe viral infections), plasma exchange has been associated with marked drops in pro-inflammatory cytokines, ferritin, and coagulation activation markers, alongside physiologic stabilization in small series and pilot studies. While larger randomized data are pending, its role as a “cytokine sink” in severe inflammation is biologically plausible and increasingly explored. (PMC, Lippincott Journals, ScienceDirect)

Autoimmune and immune-complex–driven disorders (vasculitides, neurologic autoimmune syndromes, rheumatologic diseases) have long been treated with TPE to physically remove pathogenic antibodies and immune complexes—one reason the therapy appears on multiple guideline-supported indication lists. (PMC, Archives of Rheumatology, AJKD)

4. Healthy Aging / Longevity Science (Emerging)

Exciting translational work suggests that diluting the plasma milieu in older organisms may “reset” signaling toward a more youthful state. In mice, exchanging old plasma for albumin-based fluid rejuvenated tissue repair and stem cell function. (Berkeley News)

Early human work from the Conboy group reported that “old plasma dilution” via a clinical TPE-like protocol shifted molecular biomarkers consistent with a reduction in biological age signatures. These exploratory data are preliminary but intriguing for those pursuing aggressive longevity strategies. (PubMed, Berkeley Engineering)

Who Is a Candidate in Our Program?

We evaluate TPE on an individualized basis. You may be a good fit if you fall into one (or more) of these groups:

1. Prevention-Focused Individuals at High Risk for Heart Attack or Stroke. Especially if traditional therapies have not fully controlled risk or if you prefer an integrative, data-driven approach. (AHA Journals, Lipid Insights)
   
2. People With Abnormal Cholesterol Profiles—Including Elevated Lp(a). Persistent high Lp(a) despite optimal lifestyle and medication? Plasma exchange–based lipid removal is the most effective current strategy for rapid mass reduction. (American College of Cardiology, PMC, AHA Journals)
   
3. Those With Laboratory or Clinical Signs of Chronic Inflammation. Refractory inflammatory or immune-mediated conditions may benefit from circulating factor removal. (PMC, PMC, Archives of Rheumatology)
   
4. Patients Interested in Advanced Antiaging Interventions Under Medical Supervision. While still investigational, plasma dilution approaches to improve aging biomarkers are being studied; we offer consultation for appropriately selected, health-optimization patients. (PubMed, Berkeley Engineering)
   

(We also consider certain neurologic, autoimmune, and toxin-related scenarios case-by-case; ask us if you’re unsure.) (AJKD, Medscape)

What Happens During a TPE Session?

1. Intake & Monitoring – Vital signs, recent labs (including coagulation, calcium status, lipids, and inflammatory markers), and treatment goals are reviewed. (AJKD, Medscape)

2. Vascular Access – Most patients receive one or two large-bore peripheral IV lines; central access is rarely needed in our prevention cohort. (Cleveland Clinic, Medscape)

3. Separation Phase – Your blood passes through an automated apheresis device that spins or filters to separate plasma from blood cells. (Cleveland Clinic, AJKD)

4. Plasma Removal & Replacement – Targeted plasma volume is removed. Your blood cells are mixed with sterile 5% albumin solution and balanced electrolytes (saline-based fluids)—no donor plasma in our program—and returned continuously. (AJKD, Saint Luke’s Health System Kansas City)

5. Cycle Duration – A typical preventive or lipid-focused session lasts ~1.5–2 hours; therapeutic volumes vary with body size and goals. (Cleveland Clinic, Medscape)

6. Aftercare – We recheck vitals; you may feel tired but most resume normal light activity the same day. Hydration and mineral repletion (especially calcium) are reviewed. (Cleveland Clinic, Medscape)

How Many Sessions Will I Need?

Protocols differ:

1. Cardiovascular / Lp(a): Often weekly or biweekly blocks initially, then maintenance based on lipid rebound and clinical response. (AHA Journals, Lipid Insights)
   
2. Neurodegenerative (modeled on AMBAR): Structured series over months with tapering frequency. (PubMed, PMC)
   
3. Inflammation Flares: Short, closely spaced treatments during active disease, with reassessment. (PMC, PMC)
   

We personalize scheduling around your biomarkers, symptoms, and goals. (AJKD, Medscape)

Safety, Side Effects & Monitoring

TPE is generally well tolerated in experienced centers. Potential, usually transient, effects include low blood pressure, lightheadedness, citrate-related low calcium symptoms (tingling, cramps), and access-site bruising. Because albumin solutions lack clotting factors, we track fibrinogen and coagulation status over multi-session courses and adjust intervals accordingly. Serious complications are rare with modern equipment and protocols. (Cleveland Clinic, AJKD, Medscape)

Our Arizona Experience: TPE With Dr. Keith Smigiel

At Natural Heart Doctor’s Arizona office, Dr. Keith Smigiel leads our therapeutic plasma exchange and preventive apheresis program in collaboration with our cardiology team.

What to expect with us:

1. Comprehensive risk review (lipids including Lp(a), inflammatory markers, toxin burden, cardiovascular imaging, and clinical history).
   
2. Shared decision-making: preventive vs. therapeutic goals, treatment cadence, and integration with lifestyle, supplements, and advanced testing.
   
3. Comfortable infusion suite with continuous monitoring.
   
4. Customized post-exchange recovery plan: mineral replacement, antioxidant support, and follow-up labs to track lipid and inflammation shifts.
   

Our integrative model is designed for motivated prevention and performance patients who want to “get upstream” of cardiovascular and neurodegenerative disease. (AJKD, AHA Journals, PubMed)

Frequently Asked Questions

Will this replace my medications?
Not necessarily. We collaborate with you (and your prescribing physicians) to integrate TPE with evidence-based nutrition, supplements, and, when needed, pharmaceuticals. Many patients aim to reduce medication burden as biomarkers improve. (AHA Journals, American College of Cardiology)

How soon will I see lipid changes?
Lipoprotein fractions drop immediately after a session; the magnitude and rebound rate guide ongoing frequency. Some patients notice symptom improvement (e.g., less chest pressure) within weeks. (Lipid Insights, AHA Journals)

Is TPE proven to prevent heart attacks?
Randomized hard-outcome trials are limited, but long-term observational registries in severe dyslipidemia populations show fewer cardiovascular events versus historical controls when lipids (especially Lp(a)) are aggressively lowered with apheresis. (AHA Journals, Lipid Insights, PMC)

Can it help me live longer?
Longevity data are preliminary. Plasma dilution has produced youthful shifts in biological markers in early human research and tissue rejuvenation in animal models. We view TPE as a promising adjunct, not a stand-alone antiaging cure. (PubMed, Berkeley News, Berkeley Engineering)

Ready to Explore Tissue Plasma Exchange?

If you’re at elevated cardiovascular risk, have tough-to-treat cholesterol (especially high Lp(a)), struggle with chronic inflammation, or are proactively pursuing advanced antiaging strategies, schedule a consultation with Dr. Keith Smigiel in Arizona to see whether TPE fits your personalized prevention plan. (AHA Journals, PubMed, AJKD)

Click HERE to speak with Dr. Smigiel about plasma exchange (packages start at $7500) and other 21st century biohacks. Free consultation.